Our laboratory has been credited for the discovery of a unique membrane 
Introduction
In our earlier publications [1, 2] evidences were given for the existence of a novel enzyme acetoxy drug: protein transacetylase (TAase) present in rat liver microsomes. The enzyme, transacetylse catalyzed the transfer of acetyl group from the various acetoxy drugs to specific enzyme proteins such as cytochrome P-450 (Cyt. P-450) [3] , NADPH cytochrome c-reductase [4] and glutathione S-transferase [1, 2, 5] . The simple assay procedures were developed by modifications in the literature procedures for the liver microsomal transacetylase assays [1] . The TAase assay procedure was based on the irreversible inhibition of GST (protein substrate) with the use of various acetoxy derivatives of heterocyclic molecules (second substrates) [1, 2] . One of the products of the transacetylase reaction was identified as the hydroxyl derivatives of the respective acetoxy derivatives [1] . The functional protein, NADPH cytochrome c-reductase assay was based on the activation of an enzyme participating in hepatic microsomal electron transport and Cyt. P-450 assay was based on the inhibition of liver microsomal Cyt. P-450, linked mixed function oxidases (MFO) by acetoxy derivatives of heterocyclic molecules catalyzing the epoxidation of aflatoxin B 1 (AFB 1 ) [3] . Apart from these activities we have also used the polyphenolic peracetates (PA) to modify another protein called Nitric Oxide Synthase (NOS). As enhanced intracellular levels of Nitric Oxide (NO) helps vasorelaxation in asthmatic patients. The intracellular level of NO alteration is controlled by the mechanism involved in the activation of NOS. Our studies, for the first time highlighted the role of PA as the novel potent agent for enhancing the intracellular levels of NO [6] . We had also demonstrated TAase catalyzed modification of Protein Kinase C (PKC) activity in lymphocytes of asthmatic patients by PA. The PKC activity of lymphocytes of asthmatic patients was noticed to proportionally increase with severity of the disease [7] . Acetoxy derivatives were found to exert inhibitory action on PKC while hydroxyl derivatives of the respective compounds did not show any activity. We had also highlighted the activation of human platelets NOS by PA catalyzed by Transacetylase (TAase) [6] . Purified human placental TAase mediated acetylation of nNOS by DAMC was demonstrated [8] . It was thought interesting to examine more and more acetoxy drugs to find out a better substrate for the transacetylase mediated biological actions. In this connection, eight novel 4-methylcoumarins were synthesized and characterized by spectral data (UV, IR, 1 H NMR and 13 C NMR) to examine structure activity relationship (SAR) of acetoxy, propoxy and butoxy derivatives of 4-methylcoumarin on liver microsomal Cyt. P-450 linked MFO, NADPH cytochrome creductase and cytosolic glutathione S-transferase (GST).
Results and Discussion
The 4-methylcoumarins (3-6 & 9-12) were synthesized by the well known Pechmann condensation [9] in quantitative yield. The compound 3-6 & 9-12 are outlined in scheme 1.
Structure of the compounds was confirmed by the 1 H NMR, 13 proteins catalyzed by the novel enzyme acetoxy drug: protein TAase has also been established by our earlier studies [10, 11] . DAMC, 2 a model acetoxy drug was found to modulate the activities of enzyme proteins, such as cytochrome P-450 linked MFO, NADPH cytochrome c reductase and cytosolic GST catalyzed by TAase [3, 4] . Our previous studies have highlighted the structural features of polyphenolic acetates determining the specificity for liver microsomal TAase [12, 13] .
The acetoxy coumarins were also examined for the ability to irreversibly activate liver microsomal NADPH cytochrome c reductase, which is taken as another yardstick to assess the activity and specificity of TAase (Table 2) Similar trend also persisted for compounds 8 and 10 (Table 3) . We have also examined propoxy and butoxy derivative of 4-methylcoumarin for the first time for the modulation of above described functional proteins. The results presented in Table 1 
Chemistry Known 4-methylcoumarin derivatives
The 7,8-dihydroxy-4-methylcoumarin (1) and 7-hydroxy-4-methylcoumarin (7) were prepared by well known Pechmann condensation of pyragallol and resorcinol with ethylacetoacetate [9] , the acetoxy derivatives 7,8-diacetoxy-4-methylcoumarin (2), 7-acetoxy-4-methylcoumarin (8) and butoxy derivatives 7,8-dibutoxy-4-methylcoumarin (13), were synthesized by the acetylation and butylation of their hydroxyl derivatives with acetic anhydride and butyric anhydride with pyridine and characterized according to the data reported in literature [14] .
7,8-Dihydroxy-4-methyl-2-oxo-2H-chromene-5-carboxylic acid (3)
Prepared as white colored powder from 3,4,5-trihydroxy benzoic acid (5.8 mM)
by procedure described in compound 5. Crystallized from ethanol (50% yield).; MP: 
7,8-Bis(acetyloxy)-4-methyl-2-oxo-2H-chromene-5-carboxylic acid (4)
White colored powder from compound 3 (0.04 mM), prepared as described in the preparation of compound 6. Crystallized from chloroform (80% yield 
7,8-Dihydroxy-4-methyl-2-oxo-2H-chromene-6-carboxylic acid (5)
7,8-dihydroxy-4-methylcoumarin-6-carboxylic acid (5) 
7,8-Bis(acetyloxy)-4-methyl-2-oxo-2H-chromene-6-carboxylic acid (6)
The acetylated compound 7,8-diacetoxy-6-carboxylic-4-methylcoumarin (6) was prepared by the acetylation of compound 5 (0.0 4mM) by stirring it at room temperature for 5 hrs with acetic anhydride (0.08 mM) and pyridine (0.06 mM) and the progress of the reaction was monitored on TLC using ethyl acetate: petrol 
4-Methyl-2-oxo-7,8-dipropoxy-2H-chromene-5-carboxylic acid (11)
Prepared as white colored powder from compound 3 (0.08 mM), by procedure described in the preparation of compound 6. Crystallized from chloroform (55 % yield 
4-Methyl-2-oxo-7,8-dipropoxy-2H-chromene-6-carboxylic acid (12)
The propoxy derivative of compound 5 (0.08 mM) was synthesized by the propylation with propionic anhydride (0.16 mM) and pyridine (0.12 mM) and the white colored product was obtained according to the procedure given in the preparation of compound 6. Crystallized from chloroform (60 % yield 
Animals
Male albino rats of wistar strain weighing around 180-200 g. fed on rat chow supplied by Hindustan Lever Ltd., Mumbai (India) were used.
Preparation of microsomes and cytosol
Rats were killed by decapitation, liver removed and 30% homogenate (w/v) was prepared in 10 mM phosphate buffer containing 0.25 M sucrose and 1.4 mM β-mercaptoehtanol, pH adjusted to 7.0. The homogenate was centrifuged at 10,000g
for 30 min. and the obtained supernatant was spun at 100,000 g for 1 h in the Beckman ultracentrifuge Model L-7. The cytosolic fraction was set-aside at -20 °C.
The microsomal pellet was resuspended in 0.25 M sucrose. Protein contents of microsomes and cytosol were estimated by the method of Lowry et al. [15] .
Assay of acetoxy drug: protein transacetylase
The principle governing the TA assay and the detailed assay procedure were given in our earlier publication [1] . The assay was carried out using acetoxy drug as the first substrate and cytosolic GST as the second substrate. The assay mixture in a total volume of 0.8 mL consisted of 0.25 M phosphate buffer (pH 6.5), liver microsomes (25.0 µg protein), Acetoxy drug dissolved in DMSO (100 µM), liver cytosol (12.5 µg protein) and water to make up a total volume of 0.8 mL. The contents of the tubes (Scaled up as per requirement) were preincubated at 37 °C.
The aliquots (0.8 mL portion) were removed periodically into a spectrophotometer cuvette containing CDNB and GSH to make their final concentration of 1 mM in a total volume of 1.0 mL and GST activity was assayed by following absorption at 340
nm [1] . The units of TA present were expressed in terms of percent inhibition of GST under the conditions of the assay.
Assay for AFB 1 binding to DNA
Liver microsomes catalyzed AFB 1 binding to DNA in vitro and inhibition by acetoxy drugs was carried out as described in our earlier publications [3] .
Assay for ethoxyresorufin O-dealkylase (EROD) and pentoxyresorufin Odealkylase (PROD)
The assay of EROD/PROD was performed by the method of Lubet et al. [16] .
Modulation of NADPH cytochrome C-reductase
The method consisted of preincubation of acetoxy drug with microsomes followed by addition of substrates for the reductase assay (Cytochrome c and NADPH) as described earlier [4] . The rat liver microsomes (40 µg protein) were mixed with acetoxy drug dissolved in DMSO (5 µM), 0.005 M phosphate buffer (pH 7.7) and water to make 0.5 mL volume. The contents, scaled up as per the Synthesis of Novel 4-Methylcoumarins and Comparative Specificities of Substituted … 411 requirement, were preincubated at 37 °C in a shaker water bath. The aliquots (0.5) mL portion) were removed periodically into spectrophotometer cuvette (1 cm light path) containing 0.1 mM EDTA, 36 mM cytochrome C and 1mM NADPH in a total volume of 1 mL. The progress of the reaction was followed by monitoring absorption at 550 nm. In the control samples, acetoxy drugs were replaced by DMSO. The increment in reductase activity due to acetoxy drug over the control was expressed as percent activation.
Statistical analysis
The final values are the mean of three observations and standard deviation was calculated with the help of following website: A semi empirical procedure was used to study the enzyme mediated transacetylation reactions of various acetoxycoumarins. The molecular spatial structure and bond length analysis of these systems was theoretically estimated using HyperChem Release 5.1 Pro Quantum Chemistry Package [17] . The preliminary PM3 optimized structures were subjected to a systematic conformational search and the lowest energy conformation obtained was then fully optimized without geometric constraints using RHF/PM3 semi empirical methods [18] .
Conclusion
Eight novel 4-methylcoumarins were synthesized and their structures were confirmed by the spectral data. The results presented in this communication revealed that the ortho diacetoxy system is better than those of ortho dipropoxy and dibutoxy system with respect to catalytic activity of glutathione S-transferase, NADPH cytochrome c-reductase, AFB 1 -DNA binding and cytochrome P-450 linked MFO. Introduction of carboxylic group at any position in the benzenoid ring of the coumarin moiety is ineffective in the modulation of aforesaid functional proteins.
